Psychedelic Startups, Biotech, Drug Discovery, Psilocybin, DMT, Psychedelics & Society | Sam Banister | 79
Mind & Matter
00:00
Drug Development in Depression and Related Psychiatric Conditions
There hasn't been a lot of drug development in psychiatry since the nineties. The brain is so complex that engaging any single target there typically doesn't produce, you know, a desirable sort of therapeutic outcome. So following the genomic revolution, people have movedto very much target base drug disc very hyh thruplet screens to identify a new hit and optimize it. That works super well for some areas of disease. It doesn't work so well for der psychiatry,. just because the brain is so complicated.
Transcript
Play full episode
